24 |
FDA Technology Transfer |
Oncology |
Cell therapy |
Chimeric Antigen Receptor (CAR)-T cells Targeting IL-13Rα2 Positive Human Solid Cancers
|
24 |
The Ohio State University |
Oncology |
Small molecule |
STAT3 Inhibitors and Their Anti-Cancer Usage
|
23 |
The Ohio State University |
Immunology, Oncology |
Antibody |
Improving Immunotherapy with mRNA Delivery
|
23 |
Dana-Farber |
Oncology |
Cell therapy |
LMP1 Based Approach to Producing Multi-specific CD4+ CTLs for Cancer Immunotherapy
|
22 |
Dana-Farber |
Oncology |
Nucleotide |
Antisense Inhibitors of Long Noncoding RNA as Treatment for Multiple Myeloma
|
22 |
Stanford University |
Genetic disorders |
Gene therapy |
S06-098: Novel AAV capsids with new transduction and nonimmune properties
|
21 |
Stanford University |
Immunology, Oncology |
Cell therapy |
MicroRNA Expression in Dendritic Cells for Immune Regulation
|
21 |
Cancer Research Horizons |
Oncology |
Peptide |
ɑvß6-binding Peptides for Tumour Targeting and Imaging
|
20 |
Cancer Research Horizons |
Oncology |
Antibody Conjugated |
CLEC 14A antibody
|
20 |
Stanford University |
Oncology |
Antibody |
Methods to Treat Malignant Pediatric Brain Tumors Using Anti-CD47 Agents
|
19 |
Stanford University |
Ophthalmology |
Gene therapy |
miR-494 inhibitor, for the treatment of retinal disease
|
19 |
Cancer Research Horizons |
Oncology |
Antibody |
Arginase-2 Inhibitory Antibody
|
18 |
Boston University |
Oncology |
Antibody |
High-performance Multiplex Drug-gated CAR Circuits
|
18 |
Stanford University |
Various diseases |
Antibody |
S18-179: Lysosome targeting chimeras
|
17 |
NIH |
Oncology |
Small molecule |
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
|
17 |
Boston University |
Oncology |
Gene therapy |
Orthogonal Inducible Cas13 Platform for Programmable RNA Regulation
|
16 |
Weill Cornell Medicine |
Immunology, Oncology, Ophthalmology |
Small molecule |
Irreversible S1PR2 Antagonists for the Treatment of Inflammation and Fibrosis
|
16 |
NIH |
Oncology |
Nanoparticle |
Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery
|
15 |
NIH |
Oncology, Infectious disease |
Nucleotide |
siRNA Delivery Using Hexameric Tetrahedral RNA Nanostructures
|
15 |
Weill Cornell Medicine |
Immunology, Oncology |
Protein |
Inflammasome Agonist Proteins for Vaccine and Immunotherapy
|